Equibles does not estimate personal net worth.
Get an email with a short summary when Rani Therapeutics Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get RANI alertsThe proxy statement of Rani Therapeutics Holdings, Inc. reports total compensation of $943,937 for Kate McKinley in fiscal 2025, including a base salary of $370,472. Disclosed compensation is on record for 2 fiscal years. Kate McKinley has spoken on 1 investor event across 1 company, most recently for Rani Therapeutics Holdings, Inc. on October 20, 2026. Rani Therapeutics Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rani Therapeutics Holdings, Inc. includes Lisa Rometty (CEO), Talat Imran (CEO and Board Member), Mir Imran (Chairman) and 7 others.
“So first, we'll step back and talk a little bit about the partnership that Ronnie has with Progen, which is a company based in South Korea. Ronnie and Progen have a strategic partnership for the oral delivery of Progen's PG-102 via the Ronnie pill.”
Proxy statement
Start not stated–present
Last confirmed April 16, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Business Officer | $370,472 | $943,937 |
| 2024 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Business Officer | $390,000 | $1,265,456 |
